Prelude Capital Management’s Medtronic MDT Stock Holding History

Prelude Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,300	Closed	-$1.85M	–	1948
2019 Q1	$1.85M	Sell	20,300 -15,400	-43%	-$1.38M	0.1%	200
2018 Q4	$3.25M	Buy	+35,700	New	+$3.34M	0.22%	88
2016 Q4	–	Sell	-12,000	Closed	-$1.04M	–	1688
2016 Q3	$1.04M	Hold	12,000	–	–	0.11%	206
2016 Q2	$1.04M	Buy	+12,000	New	+$970K	0.15%	165

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Prelude Capital Management's MDT Position: Q1 2026 in Review

Prelude Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 5,352 shares — an estimated $514K sold.

Prelude Capital Management first reported a position in MDT in Q3 2013 and held it in 27 quarters. The position peaked at $4M in Q1 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Prelude Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 5,352 Medtronic shares in Q1 2026, an estimated $514K.
Prelude Capital Management first reported a position in Medtronic in Q3 2013 and held it in 27 quarters.
Prelude Capital Management's Medtronic position peaked at $4M in Q1 2024.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.